Fondation Lenval   Report issue

Academic/Hospital Phase 3
Founded: Nice France (1888)

Organization Overview

First Clinical Trial
2018
NCT03525821
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CERTA Fondation Lenval, Children Hospital of Nice CHU-LENVAL | Fondation Lenval | Fondation Lenval - Nice Children Hôpitaux Pédiatriques de Nice

Active Ingredients

Drugs in Phase 3 Trials (2)

dexmedetomidine (precedex) (1 trial)

ketamine (ketalar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Emergencies (Phase 3)

Fractures, Bone (Phase 3)

Fractures, Closed (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2